Suppression of inflammatory and immune responses by the A2A adenosine receptor: an introduction
暂无分享,去创建一个
[1] V. Kuchroo,et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.
[2] Masato Kubo,et al. SOCS proteins, cytokine signalling and immune regulation , 2007, Nature Reviews Immunology.
[3] B. Cronstein,et al. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice. , 2007, Arthritis and rheumatism.
[4] A. Ohta,et al. Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues , 2007, Cancer and Metastasis Reviews.
[5] Liping Huang,et al. Activation of Adenosine 2A Receptors Attenuates Allograft Rejection and Alloantigen Recognition1 , 2007, The Journal of Immunology.
[6] S. Einav,et al. ATTENUATION OF REPERFUSION LUNG INJURY AND APOPTOSIS BY A2A ADENOSINE RECEPTOR ACTIVATION IS ASSOCIATED WITH MODULATION OF Bcl-2 AND Bax EXPRESSION AND ACTIVATION OF EXTRACELLULAR SIGNAL-REGULATED KINASES , 2007, Shock.
[7] S. Colgan,et al. Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. , 2007, The Journal of clinical investigation.
[8] G. Beller,et al. Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia. , 2007, American journal of physiology. Heart and circulatory physiology.
[9] C. Ledent,et al. Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[10] Yaqin Xu,et al. Myocardial Infarct–Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes , 2006, Circulation.
[11] K. Fuxe,et al. Targeting adenosine A2A receptors in Parkinson's disease , 2006, Trends in Neurosciences.
[12] Sumio Watanabe,et al. A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice. , 2006, Biochemical and biophysical research communications.
[13] T. Palmer,et al. Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells , 2006, Molecular and Cellular Biology.
[14] S. Friedman,et al. Adenosine A2A receptors play a role in the pathogenesis of hepatic cirrhosis , 2006, British journal of pharmacology.
[15] T. Jin,et al. Role of the exchange protein directly activated by cyclic adenosine 5'-monophosphate (Epac) pathway in regulating proglucagon gene expression in intestinal endocrine L cells. , 2006, Endocrinology.
[16] R. Schrier,et al. cAMP regulates vasopressin-induced AQP2 expression via protein kinase A-independent pathway. , 2006, Biochimica et biophysica acta.
[17] K. Taskén,et al. The molecular machinery for cAMP-dependent immunomodulation in T-cells. , 2006, Biochemical Society transactions.
[18] K. Taskén,et al. Compartmentalized cAMP signalling is important in the regulation of Ca(2+) cycling in the heart. , 2006, Biochemical Society transactions.
[19] C. Müller,et al. Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs. , 2006, Current topics in medicinal chemistry.
[20] Christopher S. Stevenson,et al. Effect of adenosine A2A receptor activation in murine models of respiratory disorders. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[21] E. Deitch,et al. Adenosine A2A receptor activation reduces lung injury in trauma/hemorrhagic shock* , 2006, Critical care medicine.
[22] Liping Huang,et al. Renal Ischemia-Reperfusion Injury and Adenosine 2A Receptor-Mediated Tissue Protection: The Role of CD4+ T Cells and IFN-γ1 , 2006, The Journal of Immunology.
[23] J. Linden,et al. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. , 2005, The Biochemical journal.
[24] J. Zezula,et al. Heterotrimeric G Protein-independent Signaling of a G Protein-coupled Receptor , 2005, Journal of Biological Chemistry.
[25] J. Scott,et al. Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract , 2005, FEBS letters.
[26] G. Byk,et al. Involvement of Adenosine in the Antiinflammatory Action of Ketamine , 2005, Anesthesiology.
[27] A. Ohta,et al. Oxygenation Inhibits the Physiological Tissue-Protecting Mechanism and Thereby Exacerbates Acute Inflammatory Lung Injury , 2005, PLoS biology.
[28] G. Beller,et al. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium. , 2005, American journal of physiology. Heart and circulatory physiology.
[29] Liping Huang,et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. , 2005, American journal of physiology. Renal physiology.
[30] K. Clark,et al. The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes. , 2005, Biochemical pharmacology.
[31] S. Colgan,et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. , 2004, Blood.
[32] S. Colgan,et al. Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia , 2004, The Journal of experimental medicine.
[33] T. Palmer,et al. Specific Inhibition of Nuclear Factor-κB–Dependent Inflammatory Responses by Cell Type-Specific Mechanisms upon A2A Adenosine Receptor Gene Transfer , 2004, Molecular Pharmacology.
[34] B. Cronstein,et al. Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages , 2004, Journal of leukocyte biology.
[35] M. Cerqueira. The future of pharmacologic stress: selective A2A adenosine receptor agonists. , 2004, The American journal of cardiology.
[36] A. Ohta,et al. Cutting Edge: Physiologic Attenuation of Proinflammatory Transcription by the Gs Protein-Coupled A2A Adenosine Receptor In Vivo , 2004, The Journal of Immunology.
[37] Manfred Thiel,et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. , 2004, Annual review of immunology.
[38] S. Jalkanen,et al. IFN-α Induced Adenosine Production on the Endothelium: A Mechanism Mediated by CD73 (Ecto-5′-Nucleotidase) Up-Regulation1 , 2004, The Journal of Immunology.
[39] Courtney M. Lappas,et al. Activation of A2A adenosine receptors inhibits expression of α4/β1 integrin (very late antigen‐4) on stimulated human neutrophils , 2004 .
[40] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[41] B. Cronstein,et al. Th1 Cytokines Regulate Adenosine Receptors and Their Downstream Signaling Elements in Human Microvascular Endothelial Cells 1 , 2003, The Journal of Immunology.
[42] Liping Huang,et al. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. , 2003, The Journal of clinical investigation.
[43] B. Fredholm,et al. Signalling from adenosine receptors to mitogen-activated protein kinases. , 2003, Cellular signalling.
[44] K. Jacobson,et al. Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium , 2003, The Journal of experimental medicine.
[45] P. Heinrich,et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.
[46] S. Vogel,et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. , 2003, The American journal of pathology.
[47] M. Sitkovsky. Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. , 2003, Biochemical pharmacology.
[48] J. Beavo,et al. Cyclic nucleotide research — still expanding after half a century , 2002, Nature Reviews Molecular Cell Biology.
[49] J. Fozard,et al. Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. , 2002, European journal of pharmacology.
[50] A. Ohta,et al. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage , 2001, Nature.
[51] B. Fredholm,et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.
[52] B. Cronstein,et al. Inflammatory Cytokines Regulate Function and Expression of Adenosine A2A Receptors in Human Monocytic THP-1 Cells1 , 2001, The Journal of Immunology.
[53] S. Rivkees,et al. Influences of adenosine on the fetus and newborn. , 2001, Molecular genetics and metabolism.
[54] C. Hall,et al. FK506 promotes adenosine release from endothelial cells via inhibition of adenosine kinase. , 2001, European journal of pharmacology.
[55] T. Skalak,et al. Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation. , 2001, American journal of physiology. Heart and circulatory physiology.
[56] J. Linden,et al. Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A2A receptor agonists , 2001 .
[57] S. Colgan,et al. Regulation of Endothelial CD73 by Adenosine: Paracrine Pathway for Enhanced Endothelial Barrier Function1 , 2000, The Journal of Immunology.
[58] Wyeth Wasserman,et al. Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[59] E. Ongini,et al. A2A adenosine receptors in human peripheral blood cells , 2000, British journal of pharmacology.
[60] M. Freissmuth,et al. Activation of Mitogen-activated Protein Kinase by the A2A-adenosine Receptor via a rap1-dependent and via a p21 ras -dependent Pathway* , 1999, The Journal of Biological Chemistry.
[61] M. Sitkovsky,et al. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. , 1999, Molecular pharmacology.
[62] C. Taylor,et al. Neutrophil-derived 5′-Adenosine Monophosphate Promotes Endothelial Barrier Function via CD73-mediated Conversion to Adenosine and Endothelial A2B Receptor Activation , 1998, The Journal of experimental medicine.
[63] S. Schiffmann,et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.
[64] B. Cronstein,et al. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. , 1996, Journal of immunology.
[65] M. Leist,et al. Concanavalin A—induced T‐cell—mediated hepatic injury in mice: The role of tumor necrosis factor , 1995, Hepatology.
[66] B. Cronstein,et al. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. , 1993, The Journal of clinical investigation.
[67] A. Wendel,et al. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.
[68] B. Cronstein,et al. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[69] G. Ghai,et al. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. , 1989, The Journal of pharmacology and experimental therapeutics.
[70] A. Lokshin,et al. Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2/NKp46-Activated NK cells , 2006, Immunologic research.
[71] E. Hill,et al. Intracellular targeting of phosphodiesterase-4 underpins compartmentalized cAMP signaling. , 2006, Current topics in developmental biology.
[72] B. Cronstein,et al. Adenosine: an endogenous regulator of innate immunity. , 2004, Trends in immunology.
[73] J. Linden,et al. Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. , 2001, British journal of pharmacology.
[74] J. Linden. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.
[75] M. Leist,et al. Concanavalin A - induced T-cell - mediated hepatic injury in mice : The role of tumor necrosis factor , 1995 .